LOW
55
2
HOG
42
3
GM
65
5
EFX
43
-9
PRGO
50
-5
CHK
27
7
HSIC
53
3
MLM
69
2
FDX
61
13
DOV
71
2
SRCL
50
3
VRTX
60
2
XRX
64
-2
IVZ
40
2
ADP
65
4
MTCH
48
-2
GOOGL
66
2
CAH
41
-7
A
43
2
MMC
51
-2
LOW
55
2
HOG
42
3
GM
65
5
EFX
43
-9
PRGO
50
-5
CHK
27
7
HSIC
53
3
MLM
69
2
FDX
61
13
DOV
71
2
SRCL
50
3
VRTX
60
2
XRX
64
-2
IVZ
40
2
ADP
65
4
MTCH
48
-2
GOOGL
66
2
CAH
41
-7
A
43
2
MMC
51
-2
Financhill
Back

uniQure NV 10K Form

Sell
14

QURE
uniQure NV

Last Price:
4.83
Seasonality Move:
-0.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive QURE News And Ratings

See the #1 stock for the next 7 days that we like better than QURE

QURE Financial Statistics

Sales & Book Value

Annual Sales: $15.84M
Cash Flow: $-51.58M
Price / Cash Flow: 0
Annual Sales: $4.34
Price / Book: 1.11

Profitability

EPS (TTM): -6.48000
Net Income (TTM): $-308.48M
Gross Margin: $2.22M
Return on Equity: -89.75%
Return on Assets: -38.73%

uniQure NV Earnings Forecast

Key uniQure NV Financial Ratios

  • The Gross Profit Margin over the past 11 years for QURE is 13.98%.
  • The Selling, General & Administrative Expenses for QURE have been equal to 470.81% of Gross Profit Margin.
  • The Research & Development expenses have been 1,356.21% of Revenue.
  • The Interest Expense is -13.47% of Operating Income.
  • The Net Earning history of QURE is -1,947.09% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

uniQure NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: QURE
CUSIP: N90064
Website: uniqure.com

Debt

Debt-to-Equity Ratio: 0.49
Current Ratio: 8.85
Quick Ratio: 8.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

QURE Technical Analysis vs Fundamental Analysis

Sell
14
uniQure NV (QURE) is a Sell

Is uniQure NV a Buy or a Sell?

  • uniQure NV stock is rated a Sell
    The current uniQure NV [QURE] share price is $4.83. The Score for QURE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.